| ACS chemical neuroscience molecule spotlight on Potiga (Ezogabine). | |
| | |
MedLine Citation:
|
PMID: 22896808 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
On June 10th, 2011, the U.S. Food and Drug Administration approved Potiga (ezogabine) as an add-on medication for the treatment of seizures in adults, and it is being developed by Valeant Pharmaceuticals. |
| | |
Authors:
|
Corey R Hopkins |
Related Documents
:
|
18458868 - Coming out of the woods: do termites need a specialized worker caste to search for new ... 17294428 - First evidence for relocation of stationary food resources during foraging in a strepsi... 14749818 - Olfaction: scent-triggered navigation in honeybees. 15584778 - Following and joining the informed individual in semifree-ranging tonkean macaques (mac... 17993218 - Energy, food, and land-- the ecological traps of humankind. 12940418 - Exopeptidases and their application to reduce bitterness in food: a review. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: ACS chemical neuroscience Volume: 3 ISSN: 1948-7193 ISO Abbreviation: ACS Chem Neurosci Publication Date: 2012 Aug |
Date Detail:
|
Created Date: 2012-08-16 Completed Date: 2013-04-10 Revised Date: 2013-05-01 |
Medline Journal Info:
|
Nlm Unique ID: 101525337 Medline TA: ACS Chem Neurosci Country: United States |
Other Details:
|
Languages: eng Pagination: 632 Citation Subset: IM |
Affiliation:
|
Vanderbilt Center for Neuroscience Drug Discovery, Department of Pharmacology and Chemistry, Vanderbilt University Medical Center, Vanderbilt University, Nashville, Tennessee 37232-6600, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Anticonvulsants
/
pharmacology*,
therapeutic use Carbamates / pharmacology*, therapeutic use Epilepsy / drug therapy Humans KCNQ Potassium Channels / agonists Phenylenediamines / pharmacology*, therapeutic use Potassium Channels / agonists Randomized Controlled Trials as Topic Seizures / prevention & control United States United States Food and Drug Administration |
| Chemical | |
Reg. No./Substance:
|
0/Anticonvulsants; 0/Carbamates; 0/KCNQ Potassium Channels; 0/Phenylenediamines; 0/Potassium Channels; 12G01I6BBU/ezogabine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Unparalleled control of neural activity using orthogonal pharmacogenetics.
Next Document: Arachidonic Acid Enhances Caffeine-Induced Cell Death via Caspase-Independent Cell Death.